RVNC
Calamos Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-24,923
| Closed | -$631K | – | 972 |
|
|
2023
Q2 | $631K | Buy |
24,923
+16,811
| +207% | +$425K | ﹤0.01% | 707 |
|
|
2023
Q1 | $261K | Sell |
8,112
-5,684
| -41% | -$183K | ﹤0.01% | 850 |
|
|
2022
Q4 | $255K | Sell |
13,796
-63,874
| -82% | -$1.18M | ﹤0.01% | 912 |
|
|
2022
Q3 | $2.1M | Buy |
+77,670
| New | +$2.1M | 0.01% | 836 |
|
|
2020
Q4 | – | Sell |
-62,599
| Closed | -$1.58M | – | 742 |
|
|
2020
Q3 | $1.58M | Buy |
62,599
+29,473
| +89% | +$742K | 0.01% | 592 |
|
|
2020
Q2 | $809K | Buy |
+33,126
| New | +$809K | 0.01% | 634 |
|